Dihydroergocryptine

二氢麦角隐亭

Report date: 2025/04/23 16:55:14

NME

Base Information

Drug NameDihydroergocryptine

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine receptors agonists

TargetsDopamine receptors

Therapy Area/IndicationsMigraine DisordersAlzheimer DiseaseParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKeyneurotek

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesKeyneurotek

Active IndicationsN/A

Inactive IndicationsMigraine DisordersAlzheimer DiseaseParkinson Disease

ATC CodeN04BC03